Literature DB >> 11487622

Interactions between apolipoprotein E gene and dietary alpha-tocopherol influence cerebral oxidative damage in aged mice.

E E Reich1, K S Montine, M D Gross, L J Roberts, L L Swift, J D Morrow, T J Montine.   

Abstract

Cerebral oxidative damage is a feature of aging and is increased in a number of neurodegenerative diseases. We pursued the gene-environment interaction of lack of apolipoprotein E (apoE) and modulation of dietary alpha-tocopherol on cerebral oxidative damage in aged male and female mice by quantifying the major isomers of cerebral isoprostanes, derived from arachidonic acid (AA) oxidation, and neuroprostanes, derived from docosahexaenoic acid (DHA) oxidation. Mice fed alpha-tocopherol-deficient, normal, or -supplemented diet had undetectable, 4486 +/- 215, or 6406 +/- 254 ng of alpha-tocopherol per gram of brain tissue (p < 0.0001), respectively. Two factors, male gender and lack of apoE, combined to increase cerebral AA oxidation by 28%, whereas three factors, male gender, lack of apoE, and deficiency in alpha-tocopherol, combined to increase cerebral DHA oxidation by 81%. alpha-Tocopherol supplementation decreased cerebral isoprostanes but not neuroprostanes and enhanced DHA, but not AA, endoperoxide reduction in vivo and in vitro. These results demonstrated that the interaction of gender, inherited susceptibilities, and dietary alpha-tocopherol contributed differently to oxidative damage to cerebral AA and DHA in aged mice.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11487622      PMCID: PMC6763161     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  31 in total

Review 1.  Apolipoprotein E: from atherosclerosis to Alzheimer's disease and beyond.

Authors:  R W Mahley; Y Huang
Journal:  Curr Opin Lipidol       Date:  1999-06       Impact factor: 4.776

Review 2.  Oxidants, oxidative stress and the biology of ageing.

Authors:  T Finkel; N J Holbrook
Journal:  Nature       Date:  2000-11-09       Impact factor: 49.962

3.  Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid.

Authors:  L J Roberts; T J Montine; W R Markesbery; A R Tapper; P Hardy; S Chemtob; W D Dettbarn; J D Morrow
Journal:  J Biol Chem       Date:  1998-05-29       Impact factor: 5.157

4.  Brains of aged apolipoprotein E-deficient mice have increased levels of F2-isoprostanes, in vivo markers of lipid peroxidation.

Authors:  D Praticò; J Rokach; R K Tangirala
Journal:  J Neurochem       Date:  1999-08       Impact factor: 5.372

5.  Increased 8,12-iso-iPF2alpha-VI in Alzheimer's disease: correlation of a noninvasive index of lipid peroxidation with disease severity.

Authors:  D Praticò; C M Clark; V M Lee; J Q Trojanowski; J Rokach; G A FitzGerald
Journal:  Ann Neurol       Date:  2000-11       Impact factor: 10.422

6.  Formation of novel D-ring and E-ring isoprostane-like compounds (D4/E4-neuroprostanes) in vivo from docosahexaenoic acid.

Authors:  E E Reich; W E Zackert; C J Brame; Y Chen; L J Roberts; D L Hachey; T J Montine; J D Morrow
Journal:  Biochemistry       Date:  2000-03-07       Impact factor: 3.162

7.  Evidence for an interaction between apolipoprotein E genotype, gender, and Alzheimer disease.

Authors:  P M Bretsky; J G Buckwalter; T E Seeman; C A Miller; J Poirier; G D Schellenberg; C E Finch; V W Henderson
Journal:  Alzheimer Dis Assoc Disord       Date:  1999 Oct-Dec       Impact factor: 2.703

8.  A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

Authors:  M Sano; C Ernesto; R G Thomas; M R Klauber; K Schafer; M Grundman; P Woodbury; J Growdon; C W Cotman; E Pfeiffer; L S Schneider; L J Thal
Journal:  N Engl J Med       Date:  1997-04-24       Impact factor: 91.245

Review 9.  Oxidative alterations in Alzheimer's disease.

Authors:  W R Markesbery; J M Carney
Journal:  Brain Pathol       Date:  1999-01       Impact factor: 6.508

Review 10.  Reactive oxygen species and the central nervous system.

Authors:  B Halliwell
Journal:  J Neurochem       Date:  1992-11       Impact factor: 5.372

View more
  4 in total

Review 1.  Cyclopentenone eicosanoids as mediators of neurodegeneration: a pathogenic mechanism of oxidative stress-mediated and cyclooxygenase-mediated neurotoxicity.

Authors:  Erik S Musiek; Ginger L Milne; BethAnn McLaughlin; Jason D Morrow
Journal:  Brain Pathol       Date:  2005-04       Impact factor: 6.508

2.  Mice lacking alpha-tocopherol transfer protein gene have severe alpha-tocopherol deficiency in multiple regions of the central nervous system.

Authors:  Kishorchandra Gohil; Saji Oommen; Hung T Quach; Vihas T Vasu; Hnin Hnin Aung; Bettina Schock; Carroll E Cross; Govind T Vatassery
Journal:  Brain Res       Date:  2008-02-09       Impact factor: 3.252

3.  Lifelong vitamin E intake retards age-associated decline of spatial learning ability in apoE-deficient mice.

Authors:  Shelley R McDonald; Michael J Forster
Journal:  Age (Dordr)       Date:  2005-05-02

4.  The Subcellular Distribution of Alpha-Tocopherol in the Adult Primate Brain and Its Relationship with Membrane Arachidonic Acid and Its Oxidation Products.

Authors:  Emily S. Mohn; Matthew J. Kuchan; John W. Erdman; Martha Neuringer; Nirupa R. Matthan; Chung-Yen Oliver Chen; Elizabeth J. Johnson
Journal:  Antioxidants (Basel)       Date:  2017-11-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.